Jianguang Zhou

This inventor holds 17 USPTO granted patents and 5 published patent applications and 6 EPO patents. Top assignee: Novartis Ag. Active years: 2014-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jianguang Zhou. Retrieved from https://idiyas.com/inventor/jianguang-zhou

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 (Patent Applications = 5)

% Patents Active = 88.2

EPO Patents = 6 (Patent Applications = 8)

Average Co-Inventor Count = 6.9

ph-index = 3

Forward Citations = 16(Granted Patents)

Location History:

Suzhou, CH (2015)
Shanghai, CN (2016 - 2020)
Jiangsu, CN (2022)
Changshu/Jiangsu Province, CN (2022)
Suzhou, CN (2014 - 2023)

Company Filing History:

17 out of 3,977

Novartis Ag

patents

Years Active: 2014-2023

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11578053 - Chemical process for preparing phenylpiperidinyl indole derivatives (2023-02-14),

2. 11236076 - Reaction medium containing water-surfactant mixture (2022-02-01),

3. 11235316 - Catalysts for chemical reactions in a water-surfactant mixture (2022-02-01),

4. 11220681 - Enzymatic reaction medium containing surfactant (2022-01-11),

5. 11208398 - Chemical process for preparing phenylpiperidinyl indole derivatives (2021-12-28),

6. 10660888 - Aminoheteroaryl benzamides as kinase inhibitors (2020-05-26),

7. 10251868 - Benzothiazolone compound (2019-04-09),

8. 10188649 - Aminoheteroaryl benzamides as kinase inhibitors (2019-01-29),

9. 9913828 - Benzothiazolone compound (2018-03-13),

10. 9802887 - Process for the preparation of intermediates useful for the manufacture NEP inhibitors (2017-10-31),

11. 9763937 - Aminoheteroaryl benzamides as kinase inhibitors (2017-09-19),

12. 9278908 - Intermediates of neutral endopeptidase inhibitors and preparation method thereof (2016-03-08),

13. 9242996 - Aminoheteroaryl benzamides as kinase inhibitors (2016-01-26),

14. 9085529 - Process for the preparation of intermediates useful for the manufacture NEP inhibitors (2015-07-21),

15. 9067883 - Intermediates of neutral endopeptidase inhibitors and preparation method thereof (2015-06-30),

Title: Innovator Spotlight: Jianguang Zhou - Pioneering Inventor in Suzhou

Introduction:

Jianguang Zhou is a prolific inventor based in Suzhou, China, with an impressive track record of 17 patents to his name. His groundbreaking work in chemical processes and catalyst development has significantly impacted the pharmaceutical and chemical industries.

Latest Patents:

Among his latest patents is a revolutionary chemical process for preparing phenylpiperidinyl indole derivatives. This method involves synthesizing compounds that have significant pharmaceutical applications, showcasing Zhou's expertise in drug development. Additionally, his work on catalysts for chemical reactions in a water-surfactant mixture has led to enhanced productivity and selectivity in chemical processes.

Career Highlights:

Currently employed at Novartis AG, a global pharmaceutical company renowned for its innovative research and development, Jianguang Zhou continues to push the boundaries of scientific discovery. His role at Novartis AG allows him to apply his expertise in chemical synthesis and catalysis to drive novel drug development initiatives.

Collaborations:

Throughout his career, Zhou has collaborated closely with esteemed colleagues such as Zhongcheng Min and David Hook. These collaborations have been instrumental in advancing research projects, fostering a culture of innovation, and achieving groundbreaking results in the field of pharmaceuticals and chemical engineering.

Conclusion:

Jianguang Zhou's contributions to the field of chemical synthesis and pharmaceuticals exemplify his dedication to innovation and scientific excellence. With a rich portfolio of patents and a thriving career at Novartis AG, Zhou continues to inspire future generations of inventors and researchers to push the boundaries of what is possible in the world of science and technology.

Profile summary based on public USPTO records.